UBS Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-51,945
| Closed | -$3.05M | – | 8972 |
|
|
2023
Q4 | $3.05M | Buy |
51,945
+18,863
| +57% | +$1.11M | ﹤0.01% | 2458 |
|
|
2023
Q3 | $1.44M | Sell |
33,082
-91,686
| -73% | -$3.99M | ﹤0.01% | 2820 |
|
|
2023
Q2 | $4.51M | Buy |
124,768
+43,336
| +53% | +$1.57M | ﹤0.01% | 1997 |
|
|
2023
Q1 | $3.03M | Sell |
81,432
-58,300
| -42% | -$2.17M | ﹤0.01% | 2227 |
|
|
2022
Q4 | $6.33M | Buy |
139,732
+118,286
| +552% | +$5.36M | ﹤0.01% | 1650 |
|
|
2022
Q3 | $1.5M | Sell |
21,446
-28,316
| -57% | -$1.98M | ﹤0.01% | 2562 |
|
|
2022
Q2 | $3.34M | Buy |
49,762
+41,731
| +520% | +$2.8M | ﹤0.01% | 2047 |
|
|
2022
Q1 | $660K | Sell |
8,031
-31,607
| -80% | -$2.6M | ﹤0.01% | 3570 |
|
|
2021
Q4 | $5.82M | Buy |
39,638
+10,732
| +37% | +$1.57M | ﹤0.01% | 1962 |
|
|
2021
Q3 | $5.11M | Buy |
28,906
+23,810
| +467% | +$4.21M | ﹤0.01% | 1982 |
|
|
2021
Q2 | $823K | Sell |
5,096
-4,936
| -49% | -$797K | ﹤0.01% | 3403 |
|
|
2021
Q1 | $1.72M | Sell |
10,032
-4,258
| -30% | -$729K | ﹤0.01% | 2902 |
|
|
2020
Q4 | $3.14M | Buy |
14,290
+1,725
| +14% | +$379K | ﹤0.01% | 2236 |
|
|
2020
Q3 | $2.09M | Sell |
12,565
-12,148
| -49% | -$2.02M | ﹤0.01% | 2368 |
|
|
2020
Q2 | $2.82M | Buy |
24,713
+8,959
| +57% | +$1.02M | ﹤0.01% | 2021 |
|
|
2020
Q1 | $1.21M | Sell |
15,754
-2,226
| -12% | -$171K | ﹤0.01% | 2527 |
|
|
2019
Q4 | $2.32M | Sell |
17,980
-64,876
| -78% | -$8.36M | ﹤0.01% | 2650 |
|
|
2019
Q3 | $6.46M | Buy |
82,856
+62,322
| +304% | +$4.86M | ﹤0.01% | 1663 |
|
|
2019
Q2 | $2.12M | Buy |
20,534
+17,510
| +579% | +$1.8M | ﹤0.01% | 2471 |
|
|
2019
Q1 | $221K | Sell |
3,024
-171,857
| -98% | -$12.6M | ﹤0.01% | 3794 |
|
|
2018
Q4 | $7.42M | Buy |
174,881
+145,857
| +503% | +$6.19M | ﹤0.01% | 1441 |
|
|
2018
Q3 | $1.37M | Buy |
29,024
+26,524
| +1,061% | +$1.25M | ﹤0.01% | 2888 |
|
|
2018
Q2 | $123K | Sell |
2,500
-57,943
| -96% | -$2.85M | ﹤0.01% | 4422 |
|
|
2018
Q1 | $1.86M | Buy |
60,443
+35,233
| +140% | +$1.08M | ﹤0.01% | 2606 |
|
|
2017
Q4 | $460K | Buy |
25,210
+10,620
| +73% | +$194K | ﹤0.01% | 3518 |
|
|
2017
Q3 | $171K | Sell |
14,590
-10,701
| -42% | -$125K | ﹤0.01% | 4107 |
|
|
2017
Q2 | $93K | Buy |
25,291
+2,796
| +12% | +$10.3K | ﹤0.01% | 4331 |
|
|
2017
Q1 | $117K | Sell |
22,495
-4,745
| -17% | -$24.7K | ﹤0.01% | 4129 |
|
|
2016
Q4 | $130K | Buy |
27,240
+5,737
| +27% | +$27.4K | ﹤0.01% | 4231 |
|
|
2016
Q3 | $142K | Sell |
21,503
-494
| -2% | -$3.26K | ﹤0.01% | 3947 |
|
|
2016
Q2 | $120K | Buy |
21,997
+1,931
| +10% | +$10.5K | ﹤0.01% | 4086 |
|
|
2016
Q1 | $429K | Sell |
20,066
-19,029
| -49% | -$407K | ﹤0.01% | 3227 |
|
|
2015
Q4 | $1.24M | Buy |
39,095
+22,413
| +134% | +$708K | ﹤0.01% | 2554 |
|
|
2015
Q3 | $575K | Sell |
16,682
-1,636
| -9% | -$56.4K | ﹤0.01% | 3007 |
|
|
2015
Q2 | $576K | Sell |
18,318
-1,513
| -8% | -$47.6K | ﹤0.01% | 3160 |
|
|
2015
Q1 | $581K | Buy |
19,831
+8,071
| +69% | +$236K | ﹤0.01% | 3133 |
|
|
2014
Q4 | $218K | Buy |
+11,760
| New | +$218K | ﹤0.01% | 3736 |
|